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Abstract
LYST is a large cytosolic protein that influences the biogenesis of lysosome-related organelles, and mutation of the
encoding gene, LYST, can cause Chediak-Higashi syndrome. Recently, Lyst-mutant mice were recognized to also exhibit an
iris disease resembling exfoliation syndrome, a common cause of glaucoma in humans. Here, Lyst-mutant iris phenotypes
were used in a search for genes that influence Lyst pathways. In a candidate gene–driven approach, albino Lyst-mutant mice
homozygous for a mutation in Tyr, whose product is key to melanin synthesis within melanosomes, exhibited complete
rescue of Lyst-mutant iris phenotypes. In a genetic background–driven approach using a DBA/2J strain of congenic mice, an
interval containing Tyrp1 enhanced Lyst-dependent iris phenotypes. Thus, both experimental approaches implicated the
melanosome, an organelle that is a potential source of oxidative stress, as contributing to the disease phenotype.
Confirming an association with oxidative damage, Lyst mutation resulted in genetic context–sensitive changes in iris lipid
hydroperoxide levels, being lowest in albino and highest in DBA/2J mice. Surprisingly, the DBA/2J genetic background also
exposed a late-onset neurodegenerative phenotype involving cerebellar Purkinje-cell degeneration. These results identify
an association between oxidative damage to lipid membranes and the severity of Lyst-mutant phenotypes, revealing a new
mechanism that contributes to pathophysiology involving LYST.
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Introduction
LYST is a large cytoplasmic protein that influences several traits
relevant to human health and disease [1]. Mutations in the
encoding gene, LYST, can cause Chediak-Higashi syndrome, a
rare, autosomal recessive disorder characterized by variable
degrees of oculocutaneous albinism, immunodeficiency, prolonged
bleeding time, and progressive neurologic dysfunction [2,3]. Lyst-
mutant mice also exhibit ocular defects resembling exfoliation
syndrome [4], a common disease that is characterized by iris
defects, fibrillar accumulations, and aberrantly dispersed pigment
throughout the anterior chamber of the eye [5]. As fibrillar
material and dispersed pigment accumulate in the outflow
structures of the eye, intraocular pressure can become elevated
and a secondary form of glaucoma often ensues. The extent to
which Chediak-Higashi syndrome and exfoliation syndrome
resemble each other at a mechanistic level remains to be
determined, but both disease states clearly share important links
to LYST.
Since the time the Lyst gene was initially discovered [2,6], a
cellular framework for understanding LYST function has only
partially emerged. LYST is present in most tissues [7] and loss-of-
function mutations lead to the enlargement of lysosome-related
organelles including lysosomes, melanosomes, and platelet-dense
bodies [8]. In this enlarged state, the organelles often fail to
undergo normal movements [9–12], and exhibit altered protein
components consistent with defective protein trafficking [13–16] as
well as impaired lysosomal exocytosis leading to defects in plasma
membrane repair [11]. LYST contains relatively few motifs with
definitive function, thus providing limited insight into how LYST
protein might contribute to these defects. Domains present in
LYST include several ARM/HEAT repeats located near the
amino terminus, a perilipin domain, a BEACH domain, and seven
WD40 repeats located near the carboxy terminus [1]. Multiple
protein-protein interactions involving LYST have been identified,
including interactions with HGS, YWHAB (commonly referred to
as 14-3-3), and CSNK2B [17]. Collectively, these studies suggest
that LYST organizes protein-complexes important to lysosome-
related organelles, perhaps through interactions with membrane
domains.
Here, a genetic approach for expanding knowledge of Lyst
function is undertaken. The goal of these experiments is to
identify genetic modifiers of Lyst-mediated phenotypes in mice.
C57BL/6J mice homozygous for the beige-J mutation of the Lyst
gene (B6-Lyst
bg-J) exhibit a unique iris phenotype characterized
by iris stromal atrophy, pigment dispersion, dark iris color, and
altered morphology of the iris pigment epithelium [4,18].
Because the iris is easily assayed, we reasoned that these iris
phenotypes could form a convenient basis for genetic screens of
Lyst-dependent modifiers. Two approaches are taken, one
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background. Both experimental approaches implicate oxidative
stress as contributing to the mechanism of disease. Testing this
hypothesis directly, we found that Lyst mutation leads specifically
to an accumulation of lipid hydroperoxides. Likely a conse-
quence of impaired lysosomal exocytosis and a resulting failure
in plasma-membrane repair, these findings implicate oxidative
membrane damage as a pathological component of Lyst-mutant
phenotypes.
Results
Iris Phenotypes of Lyst-Mutant Mice Result from
Degenerative Disease
Previously, adult B6-Lyst
bg-J mice were shown to have an iris
disease involving pigment dispersion and a distinct transillumi-
nation defect [4,18]. To determine whether these phenotypes
are the consequence of altered development or an early-onset
degenerative disease, iris phenotypes of B6-Lyst
bg-J and C57BL/
6J control mice were compared throughout postnatal develop-
ment (Figure 1). While the iris of C57BL/6J mice remained
relatively constant with age (Figure 1A–1L), the iris of B6-Lyst
bg-J
mice followed a degenerative course (Figure 1M–1U; additional
time points provided in Figure S1). At 17 days of age, when
mice became just large enough to examine with an ophthalmic
slit-lamp, the iris of B6-Lyst
bg-J mice appeared relatively normal,
by both slit-lamp examination (Figure 1M and 1P) and histologic
analysis (Figure 1S). At 60 days of age, slit-lamp analyses
indicated early signs of iris disease characterized by a dark and
granular-appearing iris (Figure 1N). At this age B6-Lyst
bg-J mice
also exhibited minor concentric iris transillumination defects
(Figure 1Q), which have previously been shown to correlate with
altered morphology of the iris pigment epithelium [4]. Histologic
analysis confirmed both that the iris stroma was atrophied and
that the morphology of the iris pigment epithelium was altered
(Figure 1T). By 100–135 days of age, these changes had become
more striking (Figure 1O, 1R, and 1U), with the most notable
change being that the iris transillumination defects were more
pronounced. Collectively, these results indicate that iris disease
in B6-Lyst
bg-J mice is the consequence of an early-onset
degenerative process. Having established this, we next set out
to identify genetic modifiers of these Lyst-mutant phenotypes
that might shed light on the underlying molecular mechanisms.
Iris Degeneration in Lyst-Mutant Mice Is Suppressed by
Tyrosinase Mutation
As in the case of B6-Lyst
bg-J mice, DBA/2J mice also develop a
degenerative iris disease involving iris stromal atrophy and iris
transillumination defects [19,20]. The iris disease of DBA/2J mice
is caused by digenic interaction of two genes encoding proteins
found within melanosomes, Tyrp1 and Gpnmb [21], and can be
rescued by mutations that decrease pigment production [21,22].
To test whether pigment production is also important to the iris
disease of B6-Lyst
bg-J mice, genetic epistasis experiments were
performed. Albino B6.Tyr
c-2J mice were intercrossed with B6-
Lyst
bg-J mice to generate mice homozygous for both mutations on a
uniform C57BL/6J genetic background (B6.Tyr
c-2J Lyst
bg-J). The
rationale for this experiment was that if pigment production
contributes to Lyst-mutant phenotypes, B6.Tyr
c-2J Lyst
bg-J mutant
irides lacking pigment production should exhibit suppressed
phenotypes.
Cohorts of B6.Tyr
c-2J Lyst
bg-J mutant mice were generated and
analyzed (Figure 2). The Tyr
c-2J mutation rescued all observable
Lyst-mediated iris phenotypes, with B6.Tyr
c-2J Lyst
bg-J eyes
indistinguishable from control B6.Tyr
c-2J eyes (B6.Tyr
c-2J Lyst
bg-J,
n=20 eyes at 2–5 months, 12 eyes at 9–11 months, 72 eyes at 12–
19 months; B6.Tyr
c-2J, n=30 eyes at 2–5 months, 8 eyes at 9–11
months, 34 eyes at 12–19 months). The iris stroma of B6.Tyr
c-2J
and B6.Tyr
c-2J Lyst
bg-J eyes were free of stromal atrophy (Figure 2A
and 2B), with no accumulations of macrophages or debris in the
anterior chamber (Figure 2C and 2D). All eyes exhibited
transillumination defects typical of albino mouse eyes, with no
indication of the concentric transillumination defect characteristic
of Lyst-mutant mice (Figure 2E and 2F). Rescue was confirmed by
histologic analysis of the iris (Figure 2G and 2H; additional time
points in Figure S2). Together, these results identified Tyr as a
genetic suppressor of Lyst-mutant iris phenotypes, and indicated
that melanin production contributes to the pathological events
leading to iris disease in B6-Lyst
bg-J mice.
Lyst-Mutant Iris Phenotypes Are Enhanced by the DBA/2J
Genetic Background
To complement the candidate-driven search for potential Lyst
modifiers, a genetic background-driven approach was also
undertaken by creating and analyzing a congenic strain of
DBA/2J mice containing the Lyst
bg-J mutation (D2.Lyst
bg-J). The
rationale for this experiment was that Tyrp1 mutation, Gpnmb
mutation, or other factors from the DBA/2J genetic background
might affect Lyst-mutant iris phenotypes. After 10 generations of
backcrossing, D2.Lyst
bg-J mice homozygous for the Lyst
bg-J
mutation were generated and assayed for relevant iris phenotypes
(Figure 3). The Lyst
bg-J mutation caused a lightening of the DBA/
2J coat color (Figure S3). At all ages examined, the DBA/2J
background enhanced Lyst
bg-J ocular phenotypes (n=30 eyes of
D2.Lyst
bg-J mice 1–7 months of age). At ages when DBA/2J mice
with wild-type Lyst alleles exhibited only mild indices of iris
abnormalities (Figure 3A, 3D, and 3G), D2.Lyst
bg-J mice exhibited
severe disease (Figure 3B, 3E, and 3H) that was enhanced over
that in B6-Lyst
bg-J mice (Figure 3C, 3F, and 3I). In D2.Lyst
bg-J
irides, the extent of iris stromal atrophy and iris transillumination
defects was notably worsened, and resulted in large accumulations
of pigment within the inferior irideocorneal angle. These results
indicate that the DBA/2J genetic background enhances iris
phenotypes of Lyst
bg-J mice.
Author Summary
LYST is a poorly understood protein involved in hereditary
disease. Mutations in the encoding gene cause Chediak-
Higashi syndrome, a rare lethal disease affecting multiple
tissues of the body. Mutations in Lyst also recapitulate
features of exfoliation syndrome, a common disease
affecting the anterior chamber of the eye. Unfortunately,
the Lyst gene is quite large, rendering it difficult to study
by many molecular and cellular approaches. Here, we use a
genetic approach in mice to identify additional genetic
pathways which might modify, or prevent, the ill
consequences associated with Lyst mutation. Our experi-
ments demonstrate that Lyst mutation results in elevated
levels of oxidative damage to lipid membranes. These
results identify a previously unrecognized consequence of
Lyst mutation and a modifiable pathway of potential
clinical relevance in humans. Ultimately, knowledge of
these events will contribute to the design of new
therapeutic strategies allowing a similar alleviation of
disease in humans.
Lyst Enhancers and Suppressors
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Lyst-Mutant Iris Phenotypes
The identity of the DBA/2J modifier was subsequently shown to
be located within a small region of mouse chromosome 4 and is
likely the Tyrp1
b mutation. DBA/2J mice have a known mutation
in the Tyrp1 gene [23], which similar to the Lyst
bg-J mutation, also
causes iris stromal atrophy [19,21]. To directly test whether Tyrp1
genotype influences Lyst phenotypes in mice, a wild-type Tyrp1
allele was crossed onto the D2.Lyst
bg-J genetic background by
intercrosses with the previously described D2.Tyrp1
B6Gpnmb
B6
congenic strain of mice [24]. Irides of DBA/2J mice with differing
Lyst and Tyrp1 genotypes were subsequently compared (Figure 4).
As described above, the Lyst
bg-J mutation results in a subtle, but
readily detectable, pattern of iris transillumination defects on the
C57BL/6J genetic background (Figure 4A), a phenotype that is
greatly enhanced on the DBA/2J genetic background (Figure 4B).
Among 39 (D2.Lyst
bg-J X D2.Tyrp1
B6Gpnmb
B6)F 2 progeny
examined, a total of 11 mice exhibited transillumination defects
of two severities. Four mice homozygous for the Tyrp1
b mutation,
but with at least 1 wild-type Lyst allele, exhibited mild
transillumination defects (Figure 4C). Seven mice homozygous
for the Lyst
bg-J mutation, but with at least 1 wild-type Tyrp1 allele,
exhibited moderate transillumination defects (Figure 4D). The
severity of transillumination defects for DBA/2J mice with wild-
type Tyrp1 were greatly reduced in comparison to those in
D2.Lyst
bg-J mice (compare Figure 4D to Figure 4B). Gpnmb
genotype, which was also segregating in these crosses, had no
discernable influence. Quantification based on analysis of the
amount of red light present in images of these eyes (Figure S4) led
to the same conclusion, transillumination defects in DBA/2J mice
with wild-type Tyrp1 were significantly reduced in comparison to
those in D2.Lyst
bg-J mice (P,0.001, Student’s two-tailed t-test).
These results map a DBA/2J-derived modifier of Lyst to a small
(approximately 14–36 cM, ref [22]) congenic interval that
encompasses the Tyrp1 gene. Because the Tyrp1
b mutation is the
only known mutation within this interval in DBA/2J mice, Tyrp1
b
is likely to be the causative modifier. The TYRP1 protein is often
affiliated with an enzymatic activity as a 5, 6-dihydroxyindole-2-
carboxylic acid (DHICA) oxidase that is active in melanin
synthesis [25]. However, TYRP1 has also been reported to have
a catalase function, and as such could also broadly influence
cellular reactions to oxidative stress [26].
Lyst Mutation Results in Accumulation of Oxidatively
Damaged Membranes
The findings of both the candidate-driven and genetic
background-driven approaches suggested that Lyst influences
oxidative stress associated with melanin synthesis. To indepen-
dently test this hypothesis, lipid hydroperoxide and protein
oxidation levels were measured from iris lysates of 2–3 month-
old mice (Figure 5). All contexts of Lyst mutation resulted in
significantly higher lipid hydroperoxide levels compared to strain-
matched controls (Figure 5A). Lyst genotype, genetic background,
and the interaction between Lyst genotype and genetic background
all significantly influenced lipid hydroperoxide levels (P,0.001 in
all comparisons, two-way ANOVA). In contrast, while genetic
background significantly influenced protein carbonylation levels
(P=0.003, two-way ANOVA), Lyst genotype did not (Figure 5B).
Indices of accumulated oxidative lipid damage were also observed
from immunohistochemical analysis of 4-HNE localization (Figure
S5). Thus, the Lyst
bg-J mutation specifically altered the accumu-
lation of oxidative damage in the membrane compartment.
Importantly, the elevation in lipid hydroperoxide levels observed
in the context of different genetic backgrounds mirrored the extent
of disease sensitivity (B6.Tyr
c-2J Lyst
bg-J,B6-Lyst
bg-J,D2.Lyst
bg-J).
This correlation is consistent with the previous finding that Lyst
mutation impairs lysosomal exocytosis, which is important for
plasma membrane repair [11], and supports the notion that
oxidative membrane damage contributes to the pathology of Lyst-
mutant phenotypes.
The DBA/2J Genetic Background Induces a Lyst-Mutant
Neurodegenerative Phenotype
Oxidative membrane damage resulting from aberrant LYST
function could have particularly important ramifications for the
neurodegenerative component of Chediak-Higashi syndrome
[1,27]. Elevated levels of oxidized lipids have been observed in
several neurodegenerative diseases [28]. It is possible that the same
process responsible for rapid degeneration of the iris might, over a
longer time frame, contribute to damage in cells that are
challenged by other forms of oxidative stress, for example in
aging neurons. Supporting this, extensively aged D2.Lyst
bg-J mice
spontaneously developed a severe tremor indicative of a
neurodegenerative phenotype, whereas B6-Lyst
bg-J mice did not
(Video S1; n=5 mice per strain, 17–20 months in age). Further
histologic analysis indicated that these D2.Lyst
bg-J mice exhibited
Purkinje-cell degeneration (Figure 6). Although the D2.Lyst
bg-J
mouse cerebellum was normal in overall size and lobule
morphology (Figure 6A and 6B), it consistently contained focal
areas lacking Purkinje cells (Figure 6C–6F; n=5 mice per strain,
17–20 months in age). Analysis of sections from the spinal cord
and sciatic nerve failed to show any degenerative pathology,
suggesting limited, if any, lower motor neuron or peripheral nerve
involvement (Figure S6). These findings indicate that the DBA/2J
genetic background also uncovered a Lyst-mediated phenotype in
Figure 1. B6-Lyst
bg-J mice exhibit degenerative iris phenotypes. Coat color and iris phenotypes of C57BL/6J mice and B6-Lyst
bg-J mice at 17 days
of age (left column), 60 days of age (middle column) and100–135 days of age (right column), indicating the time course of Lyst-mediated phenotypes.(A–
C) On the C57BL/6J genetic background, the Lyst
bg-J mutation results in a dark gray coat color at all ages (B6-Lyst
bg-J mice are in front, C57BL/6J mice are
in back). (D–F) The C57BL/6J iris is characterized by an intact iris stroma, giving the iris a smooth appearance. The iris is accentuated by numerous
underlying small vessels, whichareless prominentat17 days ofagebut notableby 60–135 days ofage. Theirisis deep sienna-brownin color.(G–I)Atall
ages, the C57BL/6J iris lacks transillumination defects (the bright white circle is a reflection of the photographic flash and not an iris defect). (J–L)
Histologic images of the postnatal C57BL/6J iris. The iris stroma (thin arrow) consists of neural crest-derived melanocytes as well as dispersed collagen
and extracellular matrix. The iris pigment epithelium (arrowhead) consists of two pigmented neural epithelium-derived cell layers. (M–O) The B6-Lyst
bg-J
iris is characterized by pronounced stromal atrophy and pigment dispersion, which gives the iris a granular appearing surface. Stromal atrophy is
particularly pronounced in the peripupillary region, where a white ring of exposed tissue surrounding the pupil is evident. The B6-Lyst
bg-J iris is distinctly
dark in color, presumably as a consequence of altered melanosome structure and stromal atrophy that exposes denser pigment of the iris pigment
epithelium. (P–R) B6-Lyst
bg-J irides exhibit progressive transillumination defects, characterized by concentric rings of transillumination (red areas), which
are absent at 17 days of age, minor at 60 days of age, andpronounced by 135 days of age. (S–U) The B6-Lyst
bg-J iris develops normally up to day 17, with
an intact irisstroma (thin arrow) andiris pigment epithelium (arrowhead). By day 60, the iris stromais degenerating andpigment-engulfed macrophages
are present (open arrow). The iris pigment epithelium adopts an unusual ‘‘sawtooth’’ morphology, in which cell-cell adhesion seems to be defective. By
100 days of age, Lyst-mutant phenotypes have become more striking. J–L and S–U scale bars=25 mm.
doi:10.1371/journal.pgen.1001008.g001
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PLoS Genetics | www.plosgenetics.org 4 July 2010 | Volume 6 | Issue 7 | e1001008the CNS, causing a tremor likely mediated by Purkinje-cell
degeneration. Because of the requirement for extensive aging, it is
not yet known whether the DBA/2J-derived modifier(s) of this
neurodegenerative phenotype and the degenerative iris disease are
identical. However, given that Tyrp1 is expressed in the brain
(Figure S7) and is thought to exhibit catalase activity [26], this
seems likely.
In order to test whether the observed Purkinje-cell degeneration
also involves oxidative damage to the cell membrane, lipid
hydroperoxide levels were measured in cerebellar lysates of B6-
Lyst
bg-J and D2.Lyst
bg-J mice (n=4 mice per strain, 17–20 months
in age). An average 25% elevation in lipid hydroperoxides was
observed in cerebella of D2.Lyst
bg-J mice compared to B6-Lyst
bg-J
mice, but the trend was not statistically significant (P=0.20, two-
way ANOVA). Although no histologic defects were apparent in
the cerebral cortex or brain stem (data not shown), lipid
hydroperoxides in the cortex were elevated by an average of
14% (P,0.001, two-way ANOVA), and levels in the brain stem by
51% (P=0.04, two-way ANOVA). Despite the limited statistical
power of these results, they suggest that, as in the iris, the
sensitivity of Lyst-mutant neuronal phenotypes in the CNS may
involve elevated lipid hydroperoxide levels.
Discussion
Here we have extended knowledge of Lyst-mediated pheno-
types through studies of Lyst genetic modifiers. Taking advantage
of iris phenotypes as a convenient assay, two genetic contexts with
important modifying influences were identified. Albinism com-
pletely rescued Lyst-mutant iris phenotypes, and the DBA/2J
genetic background enhanced them. Both results implicate
melanosomes in progression of disease associated with Lyst
mutation. Because melanin production occurring in melanosomes
is a potent source of reactive oxygen species, the iris of all three
strains was tested for indices of oxidative stress by measuring
levels of protein and lipid oxidation. These experiments
demonstrated that in pigmented cells, Lyst mutation specifically
results in oxidative damage to lipid membranes, which correlates
with the overall phenotypic severity of iris phenotypes observed
among the enhancer and suppressor strains (B6.Tyr
c-2J Lyst
bg-J ,
B6-Lyst
bg-J , D2.Lyst
bg-J). Thus, these experiments with Lyst
genetic modifiers suggest that one mechanism contributing to
Lyst-mutant phenotypes is oxidative membrane damage.
B6-Lyst
bg-J mice have previously been described to exhibit
multiple features of Chediak-Higashi syndrome [1], as well as an
iris disease recapitulating aspects of exfoliation syndrome [4,18].
In mice, both disease associations are characterized by changes to
pigmented tissues, including coat color and iris morphology. From
a mechanistic perspective, these results are directly relevant to the
pathophysiology of Lyst-mutant defects in melanosomes. Eumela-
nin production occurring in melanosomes is known to be a potent
source of oxidative stress [29,30]. The mechanisms that protect
melanosomes and pigment-producing cells from this insult are not
well understood. Our current findings support the hypothesis that
Lyst influences these events by modulating the repair of oxidatively
damaged membranes. Exocytosis of intracellular vesicles plays an
important role in plasma membrane repair [31], and experiments
with cultured cells have previously demonstrated that Lyst
mutations cause defects in lysosomal exocytosis and plasma
membrane repair [11]. The oxidative membrane damage
observed in the iris may well represent an accumulation caused
by deficient repair. Thus, other defenses against oxidative damage
to lipids are presumably overcome, leading to elevated levels of
oxidatively damaged membranes and, ultimately, cellular demise
[32-34].
The identification of Tyrp1 as a likely modifier of Lyst-mutant
phenotypes challenges common notions of TYRP1 function.
TYRP1 is typically ascribed to function as a melanocyte-specific
protein involved in melanin synthesis with DHICA oxidase
activity. However, human TYRP1 appears to lack DHICA
oxidase activity [35], indicating that this activity is not evolution-
Figure 2. Albinism rescues Lyst-mutant iris phenotypes. Different
views of B6.Tyr
c-2J eyes (left column) and B6.Tyr
c-2J Lyst
bg-J eyes (right
column), indicating that Lyst-mutant iris phenotypes are completely
rescued by albinism. (A, B) Broadbeam illumination reveals that mice of
both genotypes have an intact iris. (C, D) At higher magnification, both
genotypes have a normal appearing inferior anterior chamber that lacks
the accumulations typically observed in pigmented B6-Lyst
bg-J eyes. (E, F)
Transilluminating illumination reveals that both genotypes have a
pattern typical for albino eyes, and lack any indication of the concentric
pattern characteristic of B6-Lyst
bg-J eyes. (G, H) Histologic sections of
B6.Tyr
c-2J and B6.Tyr
c-2J Lyst
bg-J irides are indistinguishable, both showing
an intact iris stroma (thin arrows) and iris pigment epithelium
(arrowheads). A portion of the lens is also visible in the bottom of both
panels. Images from 3-month-old mice. Images A, C, and E are all from
the same eye, as are B, D, and F. Magnifications: A, B (256); C, D (406,
with less image reduction); E, F (256); G, H scale bars=25 mm.
doi:10.1371/journal.pgen.1001008.g002
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only pigment producing cells where DHICA is found. Based on
our results and data provided in online databases such as the Allen
Institute for Brain Science’s Mouse Brain Atlas [36], Tyrp1 is also
expressed in the brain. An alternative function for TYRP1 that is
consistent with our current findings is to provide catalase activity
[26]. A function for TYRP1 as a catalase that influences reactive
oxygen species would be consistent with the observation that the
Tyrp1
b mutation is associated with elevated oxidative stress, and
would provide a rational explanation for its ability to enhance Lyst-
mediated oxidative membrane damage. However, in considering
potential links between Tyrp1 and Lyst, it is important to point out
a caveat of our current experiments. The D2-derived modifier has
formally been mapped only to a congenic interval containing
Tyrp1. Given that the Tyrp1
b and Lyst
bg-J mutations independently
cause similar phenotypes in the iris, it is highly likely that Tyrp1 is
the causative modifier, yet it remains possible that an as yet
unknown modifier exists in close proximity to this gene.
Experiments testing this directly are underway.
Our current findings have important implications with respect
to Chediak-Higashi syndrome. A defining component of this
syndrome is progressive neurologic dysfunction [1]. Although
bone-marrow transplantation can correct the immunological
aspects of Chediak-Higashi syndrome and significantly extend
lifespan, this treatment does not correct the neurologic aspects of
the disease [37,38]. A deeper understanding of LYST-mediated
neurodegenerative phenotypes is critical for the eventual develop-
ment of improved therapies for this condition. In the current
Figure 3. The DBA/2J genetic background enhances Lyst-mutant iris phenotypes. Three different slit-lamp views of DBA/2J (left column),
D2.Lyst
bg-J eyes (middle column), and B6-Lyst
bg-J (right column) eyes, indicating that the DBA/2J genetic background enhances iris phenotypes caused
by Lyst mutation. When viewed with broadbeam illumination: (A) 7-month-old DBA/2J eyes exhibit indices of mild iris disease, characterized by early
signs of pigment dispersion and the swelling of peripupillary tissue, with corneal calcification typical of this strain also evident; (B) 7-month-old
D2.Lyst
bg-J eyes exhibit pronounced stromal atrophy and pigment dispersion, with numerous areas of depigmentation allowing light to pass freely
through the iris and giving it a red hue; and (C) 9-month-old B6-Lyst
bg-J eyes have pronounced stromal atrophy and pigment dispersion, but the iris
remains intact overall. When viewed at higher magnification: (D) DBA/2J irides exhibit mild pigment dispersion; (E) D2.Lyst
bg-J irides exhibit severe
degeneration and have a granular appearance, with large accumulations of dispersed pigment and pigment engulfed macrophages visible inferiorly
(open arrows); and (F) B6-Lyst
bg-J eyes exhibit accumulations of dispersed pigment and pigment-engulfed macrophages that are visible inferiorly, but
the iris is less severely degenerated. When viewed with transilluminating illumination: (G) DBA/2J eyes show mild iris transillumination defects, with
subtle radial spoke-like tendencies; (H) D2.Lyst
bg-J eyes have a severe transillumination defect (evident by the increased amount of red light),
indicating a very atrophic iris; and (I) B6-Lyst
bg-J eyes exhibit a characteristic pattern of concentric transillumination defects that are far less severe
than those in eyes of D2.Lyst
bg-J mice. Images in each column are all from the same eye. Magnifications: A–C (256); D–F (406, with less image
reduction); G–I (256).
doi:10.1371/journal.pgen.1001008.g003
Lyst Enhancers and Suppressors
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neurodegenerative phenotype involving the loss of Purkinje cells
in mice with the widely utilized Lyst
bg-J mutation. Our preliminary
experiments suggest that, as in the case of the iris, the neuronal
phenotype may involve an accumulation of oxidatively damaged
membranes. Due to the large size of the neuronal cell and its
expansive plasma membrane [39], neurons are likely to be in need
of continuous membrane repair, and especially sensitive to defects
in this process. D2.Lyst
bg-J mice represent a new resource for
further dissecting these mechanisms, and for testing various anti-
oxidant therapies for potential benefit in mouse models of
Chediak-Higashi syndrome.
Our findings also have important implications with respect to
ophthalmic disease. The ocular phenotypes of B6-Lyst
bg-J mice,
particularly the iris transillumination defects, resemble those seen in
exfoliation syndrome [4]. Several studies implicate oxidative stress
as contributory to exfoliation syndrome [5], including the
observation that aqueoushumorfrom exfoliation syndromepatients
has decreased levels of catalase activity [40]. The results presented
here suggest that such changes are likely to be pathological.
Furthermore, LYST, and other genes influencing oxidative stress,
are suggested as candidates worthy of consideration for contributing
to hereditary forms of exfoliation syndrome which is likely to also be
strongly influenced by genetic modifiers [41].
Despite the existence of many Lyst alleles in mice, the resource
that this allelic series represents has only begun to be utilized in
assigning genotype-phenotype correlations. The bg-J mutation
utilized here results from a 3-bp deletion predicted to remove a
single isoleucine from the WD40 domain of the LYST protein [4].
Previous western blot analysis of cultured fibroblasts homozygous
for the bg-J mutation failed to detect LYST protein [42], suggesting
that the mutation may represent a null allele. However, this
experiment has not been performed on tissues isolated directly from
the mouse, nor have genetic complementation tests with a definitive
null (such as a deletion or targeted mutation) been performed,
leaving uncertainty regarding classification of the bg-J allele.
Neurodegenerative phenotypes have previously been described for
only one other allele (Lyst
Ing3618) [43], which like the bg-J mutation,
also disrupts the LYST WD40 domain. To our knowledge, iris
phenotypes have not yet been assessed in any Lyst mutant strains
other than those described here. Thus, it is not yet clear whether the
iris and neuronal phenotypes described here will pertain to all Lyst
alleles or might be specific to just a sub-class of mutations, though
this is an issue that is addressable and worthy of follow-up.
In addition to mutations in mice, a variety of mutations relevant
to LYST have been identified in other model organisms. One
example is the Drosophila BEACH family member, blue cheese (bchs).
Like LYST, the Bchs protein is predicted to be a large (400 kDa)
protein containing a BEACH domain followed by a series of
WD40 repeats near the C-terminus. Unlike LYST, Bchs also
contains a PI(3)P-binding FYVE domain. Mutations in bchs result
in reduced adult life span and age-related neuronal degeneration
[44]. The bchs gene exhibits genetic interactions with genes
involved in lysosomal transport and is therefore thought to encode
a scaffolding protein involved in vesicle transport [45]. In motor
neurons from bchs mutants, anterograde transport of endolysoso-
mal vesicles toward synaptic termini is particularly affected,
leading to a hypothesis that a degradative function of endolyso-
somal compartments at the neuromuscular junction is important
in preventing neuron degeneration [46]. With respect to our
current findings with Lyst mutant mice, these observations
demonstrate that lysosomes undoubtedly make several contribu-
tions important to neuronal survival and point to the opportunity
afforded by experiments with model organisms to study these
events. A direct Lyst ortholog exists in Drosophila (CG11814), but
mutant phenotypes associated with this gene have not yet been
described. In the future, it will be interesting to examine the extent
to which bchs and CG11814 mutant phenotypes resemble each
other and what additional insights might be gained by genetic
studies of these genes.
Figure 4. The DBA/2J-derived genetic enhancer of Lyst-mutant iris phenotypes maps to Tyrp1. Irides of mice from 4 different genetic
backgrounds with the Lyst
bg-J mutation indicate that Tyrp1 mutation enhances Lyst-mutant iris phenotypes. (A) Subtle transillumination defect in B6-
Lyst
bg-J eyes. (B) Severe transillumination defect in D2.Lyst
bg-J eyes. (C) Mild transillumination defect observed in (D2.Lyst
bg-J X D2.Tyrp1
B6Gpnmb
B6)F 2
mice heterozygous for the Lyst
bg-J mutation but homozygous for the Tyrp1
b mutation; note that the concentric pattern of defects resembles those of
the Lyst
bg-J phenotype. Similar results are observed in eyes of mice homozygous for wild-type Lyst alleles and the Tyrp1
b mutation. (D) Moderate
transillumination defect observed in (D2.Lyst
bg-J X D2.Tyrp1
B6Gpnmb
B6)F 2 mice heterozygous for the Tyrp1
b mutation, but homozygous for the Lyst
bg-J
mutation; note that presence of a wild-type Tyrp1 allele greatly alleviates the extent of transillumination in comparison to that in the D2.Lyst
bg-J
phenotype. Similar results are observed in eyes of mice homozygous for wild-type Tyrp1 alleles and the Lyst
bg-J mutation. Genetic background, Lyst,
and Tyrp1 genotype are summarized below each panel. The ‘‘B6’’ allele of Tyrp1 indicates the wild-type C57BL/6J allele and the ‘‘D2’’ allele of Lyst
indicates the wild-type DBA/2J allele. All mice=1 month of age.
doi:10.1371/journal.pgen.1001008.g004
Lyst Enhancers and Suppressors
PLoS Genetics | www.plosgenetics.org 7 July 2010 | Volume 6 | Issue 7 | e1001008In conclusion, we have performed both candidate-driven and
genetic background-driven experiments to identify Lyst modifiers.
A priori, the expectation would have been that modifiers of Lyst
would logically be related to organelle biogenesis. Instead, it seems
that at the level of the whole animal, oxidative damage to
membranes is a highly relevant event. In our ongoing work, we
intend to further test the links between Tyrp1 and Lyst-mediated
ophthalmic disease, and to dissect the neurodegenerative disease
uncovered in D2.Lyst
bg-J mice.
Materials and Methods
Animal Husbandry
C57BL/6J, B6-Lyst
bg-J/J (abbreviated throughout as B6-Lyst
bg-J),
DBA/2J, and B6(Cg)-Tyr
c-2J/J (abbreviated throughout as B6.Tyr
c-2J)
mice were obtained from The Jackson Laboratory, Bar Harbor,
Maine. D2.Tyrp1
B6Gpnmb
B6 mice [24] were kindly provided by Dr.
Simon John of The Jackson Laboratory and subsequently bred at
The University of Iowa. Unless otherwise noted, all experiments with
B6-Lyst
bg-J mice utilized mice homozygous for the bg-J mutation. All
mice utilized were housed and bred at the University of Iowa
Research Animal Facility. Mice were maintained on a 4% fat NIH
31 diet provided ad libitum and were housed in cages containing dry
bedding (Cellu-dri; Shepherd Specialty Papers, Kalamazoo, MI).
T h ee n v i r o n m e n tw a sk e p ta t2 1 uC with a 12-h light:12-h dark cycle.
All animals were treated in accordance with the Association for
Research in Vision and Ophthalmology Statement for the Use of
Animals in Ophthalmic and Vision Research. All experimental
protocols were approved by the Animal Care and Use Committee of
The University of Iowa.
Slit-Lamp Examination
Anterior chamber phenotypes were assayed using a slit-lamp
(SL-D7; Topcon, Tokyo, Japan) and photodocumented using a
digital camera (D100; Nikon, Tokyo, Japan). All ocular exams
utilized conscious mice. Based on previous observations of Lyst-
mutant mice [4], several traits uniformly present in adult B6-Lyst
bg-J
mice were followed for potential phenotypic modification. For
assessment of anterior chamber phenotypes, a beam of light was
shone at an angle across the eye, and the anterior chamber was
Figure 5. Lyst mutation leads to an increase in the levels of lipid
hydroperoxides. (A) Lipid hydroperoxide levels in the iris according
to genotype. (B) Protein carbonylation levels in the iris according to
genotype. Mean 6 SD; n=3 for each combination of genotype and
strain.
doi:10.1371/journal.pgen.1001008.g005
Figure 6. D2.Lyst
bg-J mice exhibit Purkinje-cell degeneration.
Mid-sagittal sections of H&E-stained cerebella revealing Lyst-mediated
Purkinje-cell degeneration. (A, B) Low-magnification views of the
cerebellar cortex, illustrating that D2.Lyst
bg-J tissues exhibit no
abnormalities of lobule formation or lobule size in comparison to B6-
Lyst
bg-J control tissues. Scale bars=0.5 mm. (C, D) Within fissures of the
cerebellar cortex, D2.Lyst
bg-J tissues exhibit a loss of Purkinje cells (open
arrows) compared to B6-Lyst
bg-J control tissues. Note that Purkinje cells
of B6-Lyst
bg-J mice form a continuous layer of closely spaced cells,
whereas there is a large gap to the left of the open arrow in panel D
from D2.Lyst
bg-J mice that is devoid of Purkinje cells. Scale
bars=100 mm. (E, F) Higher magnification images illustrating a decrease
in the density of Purkinje cells (arrows) between the molecular (above)
and granular-cell (below) layers in D2.Lyst
bg-J cerebella compared to the
same region in B6-Lyst
bg-J age-matched controls. Scale bars=50 mm. All
mice=17–20 months of age.
doi:10.1371/journal.pgen.1001008.g006
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appearance. For assessment of iris transillumination defects, a small
beam of light was shone directly through the undilated pupil of the
mouse and the iris was examined for the ability of reflected light to
pass through diseased or depigmented areas of the iris. All
photographs of like kind were taken with identical camera settings
and prepared with identical image software processing. Unless
otherwise noted, all slit-lamp images were collected at 256
magnification, cropped, and reduced in size.
Severity of iris transillumination defects was quantified by
measuring the R-value from RGB formatted digital images.
Digital images of iris transillumination defects from left and right
eyes of 4 mice per genotype were analyzed using Adobe Photoshop
software (Adobe Systems Inc., San Jose, CA). From 2 images per
eye, 2 circular sampling windows of equivalent size, each covering
approximately 5% of the measurable area of the iris, were
uniformly placed (1 superior and 1 inferior) on the temporal halves
of each iris image using the Elliptical Marquee tool. RGB values
for the sample areas were averaged using the Average Blur Filter
and R-values measured with the Eyedropper tool. In total, each
genotype of mice involved analysis of 32 sample areas whose R-
values were utilized in statistical analysis.
Histology
Samples from different tissues were processed as explained
below, and imaged using a light microscope (BX52; Olympus,
Tokyo, Japan) equipped with a digital camera (DP72; Olympus,
Tokyo, Japan).
Eyes were fixed in 2.5% gluteraldehyde in 0.1 M Na cacodylate
for 16 hours, and post fixed with 1% osmium tetroxide in 0.1 M
Na cacodylate buffer at room temperature for 1 hour. A series of
acetone dehydrations were performed followed by infiltration with
Embed-812/DDSA/NMA/DMP-30 for 24 hours. 0.5-mm sec-
tions were cut (EM UC6 ultramicrotome; Leica, Wetzler,
Germany), and stained with 1% toluidine blue.
Cerebella were cut down the midline, yielding 2 hemispheres. The
left cerebellar halves were fixed overnight at 4uCi n4 %p a r a f o r m a l -
dehyde in 1X PBS (pH 7.4), and embedded in paraffin (Tissue Prep
Paraffin Beads T565; Fisher, Pittsburgh, PA, USA). Mid-sagittal 5-
mm sections were cut (Microm HM 355; Thermo Fisher, Waltham,
MA, USA) and stained with hematoxylin-eosin (H&E).
Sciatic nerves were removed from the left hindlimb and fixed at
4uC in 2.5% osmotically-balanced glutaraldehyde in 0.1 M Na
cacodylate buffer (pH 7.4) for at least 24 hours. Following rinses
with cacodylate buffer, nerves were post fixed with 1% osmium
tetroxide in 0.1 M Na cacodylate buffer at room temperature for
1 hour. Dehydration was then carried out through a series of 40-
minute incubations in 25%, 50%, 75%, 90%, and 100% graded
ethanol. Nerves were infiltrated overnight at room temperature,
with 33%, 66%, and 100% resin (Low Viscosity Spurr Epoxy
Resin; Ted Pella, Redding, CA) in propylene oxide. Specimens
were embedded in resin, and 1-mm cross sections were cut (EM
UC6; Leica, Wetzler, Germany) and stained with toluidine blue.
Dissected spinal columns were fixed in Bouins fixative for .1
week. Following rinses with 70% ethanol, 3-mm cross sections
were cut from the cervical, thoracic, and lumbar regions of each
column. The 3 cross sections from each column were embedded in
paraffin (Tissue Prep Paraffin Beads T565; Fisher, Pittsburgh, PA),
and 5-mm cross sections were cut (Microm HM 355; Thermo
Fisher, Waltham, MA, USA) and stained with H&E.
Strain Genotyping
The Lyst
bg-J mutation results from a 3-bp deletion predicted to
remove a single isoleucine from the WD40 domain of the LYST
protein [4]. Lyst genotype was assessed by PCR amplifying a
fragment of genomic DNA that flanks the causative 3-bp bg-J
deletion [4] and assessing product lengths. To generate B6(Cg)-
Tyr
c-2J Lyst
bg-J mice (abbreviated throughout as B6.Tyr
c-2J Lyst
bg-J),
B6.Tyr
c-2J mice were bred to B6-Lyst
bg-J mice, and each region was
bred to homozygosity. The Tyr
c-2J allele is a spontaneously arising
missense mutation that also influences splicing of the tyrosinase
pre-mRNA, ultimately resulting in complete absence of the
tyrosinase protein [47]. Tyr genotype was inferred from coat
color. To generate congenic mice with the Lyst
bg-J mutation on a
DBA/2J genetic background (D2.B6-Lyst
bg-J/Andm; abbreviated
throughout as D2.Lyst
bg-J), B6-Lyst
bg-J mice were reiteratively bred
to DBA/2J mice and each successive generation genotyped to
select breeders heterozygous for the Lyst
bg-J mutation. This process
was continued for 10 generations of backcrossing. At the 10th
generation, the mice were intercrossed and the Lyst
bg-J mutation
was bred to homozygosity. Congenic mice were genotyped with
the closely linked D13Mit17 marker and confirmed by genotyping
of the causative 3 bp bg-J deletion. Genotypes of (D2.Lyst
bg-J X
D2.Tyrp1
B6Gpnmb
B6)F 2 progeny were assessed for Tyrp1 using the
flanking markers D4Mit327 and D4Mit178, and for Gpnmb using
D6Mit355 and D6Mit74.
Reverse-Transcription PCR
For reverse-transcription PCR (RT-PCR), brains were removed
and the cerebral cortex, cerebellum, and brain stem were dissected
in PBS. Samples were homogenized and RNA was extracted,
treated with DNase I, purified (Aurum Total RNA Mini Kit; Bio-
Rad Laboratories; Hercules, CA), and converted to cDNA (iScript
cDNA Synthesis Kit; Bio-Rad Laboratories; Hercules, CA). Each
PCR reaction contained: 1.5 ml 10X reaction buffer (Bioline,
Taunton, MA), 1.2 ml dNTPs, 0.25 ml5 9-primer (10 mM), 0.25 ml
39-primer (10 mM), 0.25 ml MgCl2, 9.55 mld H 2O, 0.15 ml Taq
DNA polymerase (Immolase; Bioline, Taunton, MA), and 1.5 ml
cDNA (0.66 ng/ul). Primer pairs used in PCR reactions
include: Lyst (59-CACTGGGAGCAAGTGTGGTG-39,5 9-TCA-
ATTTCTGAGGGCGTGCT-39) and Tyrp1 (59-TGCGATG-
TCTGCACTGATGA-39,5 9-TCCAGCTGGGTTTCTCCTG-
A-39). PCR conditions were: 94uC for 10 minutes, 406 (94uC
for 30 seconds, 61uC for 1 minute, 72uC for 1 minute), and 72uC
for 7 minutes. PCR products were analyzed on a 1% agarose gel
using EtBr detection.
Assays for Protein and Lipid Oxidation
Lipid hydroperoxide levels were measured directly (Lipid
Hydroperoxide Assay; Cayman Chemical Company, Ann Arbor,
MI) following the manufacturer’s protocol. To measure lipid
hydroperoxide levels in the iris, both irides of individual mice were
dissected and sonicated in ice-cold ddH2O. Total protein was
measured from a small aliquot (Bio-Rad Protein Assay; Bio-Rad
Laboratories, Hercules, CA). The remaining sample volume was
used for the extraction of lipid hydroperoxides into chloroform,
and absorbance was measured following the protocol recom-
mended by the manufacturer. Tissue lipid hydroperoxide was
expressed as nmol hydroperoxide per mg of total protein. Each
mouse strain was measured in biological triplicates from mice 2–4
months of age. Two-way analysis of variance (ANOVA) was
employed to evaluate differences among different Lyst genotypes
and genetic backgrounds.
For measurement of lipid hydroperoxide levels in the brain, the
right cerebellar and cortical hemispheres, as well as the right half
of the brain stem, were dissected and processed as described
above, with the exception that samples were analyzed in two
separate sessions. Two mice of each genotype were analyzed per
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pairing B6-Lyst
bg-J and D2.Lyst
bg-J samples from each session.
Two-way ANOVA was employed to evaluate differences among
results from different genetic backgrounds and sessions.
Protein oxidation levels were measured using an immunoblot-
ting method (OxyBlot
TM Protein Oxidation Detection Kit;
Millipore, Bedford, MA) following the manufacturer’s protocol.
Dissected irides were homogenized in lysis buffer (50 mM Tris
HCl pH 7.4, 0.15 M NaCl, 1 mM EDTA, 0.1% TritonX100,
0.1% SDS, and protease inhibitors). Two aliquots of 20 mg protein
each were analyzed. One aliquot was subjected to the derivati-
zation reaction and the other served as a negative control by
substituting 16 derivatization-control solution for 16 DNPH
solution. Samples were denatured, derivatized, and neutralized,
followed by analysis of immunoblots using an aDNP antibody.
Each sample was blotted in technical triplicates (4 ml per dot) on 2
separate membranes (Immobilon-FL PVDF; Millipore, Bedford,
MA) and allowed to dry completely. One membrane was stained
with coomassie blue and the other was blocked (Odyssey Blocking
Buffer; LI-COR Odyssey, Lincoln, NE) and incubated with aDNP
primary antibody (diluted 1:50 in blocking buffer overnight at
4uC). Following washes and incubation with secondary antibody
(IRDye 680 Conjugated Gt a Rb IgG; LI-COR Odyssey, Lincoln,
NE), blots were washed and quantified (LI-COR Odyssey
detection system; LI-COR Odyssey, Lincoln, NE). Each sample
was normalized to total protein and the amount of protein
oxidation in the wild-type C57BL/6J strain. Sample analysis was
repeated in 5 independent experiments. Normalized values were
averaged and compared by two-way ANOVA.
Anti-4-Hydroxy-2-Nonenal Antibody (4-HNE)
Immunohistochemistry
For immunohistochemistry with 4-HNE, eyes from 6 month old
mice were embedded unfixed in Optimal Cutting Temperature
embedding medium (Tissue-Tek O.C.T. Compound; Sakura
Finetek U.S.A., Inc., Torrance, CA); 10-mm sections were cut
and sections were transferred to glass slides (CryoJane, Instru-
medics, Inc., St. Louis, MO). Cryosections were air dried for 30
minutes at room temperature, fixed for 5 minutes in ice-cold
acetone, again air dried for 30 minutes at room temperature, and
rehydrated in PBS for 5 minutes. Sections were blocked (15
minutes at room temperature with 1 mg/ml BSA in PBS), labeled
with primary antibodies (1 hour at room temperature using
monoclonal mouse Anti-4-HNE antibody diluted 1:100; Oxis
International Inc., Foster City, CA), washed (three washes, 5
minutes each in PBS), and labeled with secondary antibody
(1 hour at room temperature using AlexaFluor 488 conjugated
antibody diluted 1:200; Invitrogen-Molecular Probes, Carlsbad,
CA). After 3 washes in PBS, the sections were mounted (ProLong
Gold, Invitrogen-Molecular Probes, Carlsbad, CA), and viewed by
fluorescence microscopy. All immunohistochemical experiments
used assay conditions in which controls using no primary antibody
lacked specific signal.
Supporting Information
Figure S1 Additional time points in the histologic analysis of B6-
Lyst
bg-J irides. Histologic comparison of C57BL/6J (left column) and
B6-Lyst
bg-J (right column) irides throughout postnatal development.
(A, B) At posnatal day 4 (P4), C57BL/6J and B6-Lyst
bg-J eyes are
histologically similar. Cells of the iris stroma (thin arrows) are visibly
distinguishable from the developing trabecular meshwork and
ciliary body stroma (asterisks). Pigmentation of the iris pigment
epithelium (arrowheads) is complete. (C–F) At P10 and P16,
C57BL/6J and B6-Lyst
bg-J eyes remain histologically similar. The
iris stroma and iris pigment epithelium of both genotypes are
mature and fully developed. During this time, apparent spaces
containing dispersed collagen and extracellular matrix become
evident in both genotypes. (G, H) At P24, C57BL/6J and B6-
Lyst
bg-J eyes first become distinct from one another. The B6-Lyst
bg-J
iris stroma begins to show areas of disruption that are evident by
decreased cellularity. (I, J) At P36, differences between C57BL/6J
and B6-Lyst
bg-J eyes become more defined. The B6-Lyst
bg-J iris
pigment epithelium begins to take on a ‘‘sawtooth’’ morphology,
and pigment engulfed macrophages on the stromal surface
(examples are indicated with open arrows, several others are
unmarked) become evident as stromal atrophy continues. (K–P)
At P48 and older, differences between C57BL/6J and B6-Lyst
bg-J
eyes become more striking and eventually appear to stabilize.
Scale bars=25 mm.
Found at: doi:10.1371/journal.pgen.1001008.s001 (9.44 MB TIF)
Figure S2 Additional time points in the histologic analysis of
B6.Tyr
c-2J Lyst
bg-J irides. Histologic comparison of B6.Tyr
c-2J (left
column) and B6.Tyr
c-2J Lyst
bg-J (right column) irides throughout
postnatal development. (A–F) Throughout early postnatal devel-
opment in day P4–P16 mice, B6.Tyr
c-2J and B6.Tyr
c-2J Lyst
bg-J eyes
are histologically similar. Cells of the iris stroma (thin arrows) are
visibly distinguishable from the developing trabecular meshwork
and ciliary body stroma (asterisks). Cells of the iris pigment
epithelium (arrowhead) are evident. Because of the Tyr
c-2J mutation,
all cells lack melanin pigment. (G–J) At P24 and P36, when
pigmented Lyst
bg-J eyes first begin to exhibit mutant phenotypes,
the iris of albino B6.Tyr
c-2J and B6.Tyr
c-2J Lyst
bg-J eyes remain
histologically similar. Also unlike pigmented B6-Lyst
bg-J eyes,
albino B6.Tyr
c-2J Lyst
bg-J eyes lack macrophages across the surface
of the iris stroma, a further indication of an intact healthy iris. (K–
P) With increasing age, the iris of B6.Tyr
c-2J and B6.Tyr
c-2J Lyst
bg-J
eyes remain histologically similar, indicating the rescuing influence
of the Tyr
c-2J mutation to Lyst-mutant phenotypes. Scale
bar=25 mm.
Found at: doi:10.1371/journal.pgen.1001008.s002 (8.49 MB TIF)
Figure S3 Coat-color phenotypes of D2.Lyst
bg-J mice. Coat color
of D2.Lyst
bg-J (left) and DBA/2J (right) mice. The Lyst
bg-J mutation
causes a lightening of the DBA/2J coat color.
Found at: doi:10.1371/journal.pgen.1001008.s003 (1.94 MB TIF)
Figure S4 Quantification of iris transillumination defects
confirms that the DBA/2J-derived genetic enhancer of Lyst-
mutant iris phenotypes maps to Tyrp1. Severity of transillumina-
tion defects quantified for multiple genotypes of mice. Transillu-
mination defects were quantified based upon the amount of red
light (R-value) in RGB formatted digital images of irides. As
indicated in the key, images of wild-type (WT) eyes with no
transillumination defects give rise to low R-values and eyes with
mutant (MUT) phenotypes allowing light to pass through the iris
give rise to increasing R-values. Genetic background (BGND), Lyst,
and Tyrp1 genotype are summarized below each panel. ‘‘D2’’ and
‘‘B6’’ refer to the wild-type alleles of DBA/2J or C57BL/6J mice,
respectively. The (D2.Lyst
bg-J X D2.Tyrp1
B6Gpnmb
B6)F 2 cohorts
include mice that are either homozygous or heterozygous for the
wild-type allele of Lyst (5
th bar from left) or Tyrp1 (6
th bar from left).
Note that presence of a wild-type Tyrp1 allele greatly alleviates the
extent of transillumination in comparison to the D2.Lyst
bg-J
phenotype (asterisk, P,0.001, Student’s two-tailed t-test). Mean
61 SD. n=8 eyes of 1-month-old mice per group.
Found at: doi:10.1371/journal.pgen.1001008.s004 (0.25 MB
TIF)
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labeling and lipid hydroperoxide. 4-HNE labeling of C57BL/6J
(left column) and B6-Lyst
bg-J (right column) eyes. Identical cryosections
imaged with phase-contrast (top row) or epifluorescence (bottom row)
microscopy. (A, C) C57BL/6J irides have modest 4-HNE labeling
of the iris stroma (arrows). (B, D) B6-Lyst
bg-J irides have increased
levels of 4-HNE labeling of the iris stroma (arrows), as well as
pigment engulfed macrophages (arrowhead). All other labeling is
non-specific, as determined by a negative control in which no
primary antibody was used.
Found at: doi:10.1371/journal.pgen.1001008.s005 (4.94 MB TIF)
Figure S6 D2.Lyst
bg-J mice exhibit no spinal cord or sciatic nerve
degeneration. (A, B) Cross sections of the thoracic spinal cord
stained with H&E. Images of the ventral grey matter illustrate
similar numbers of motor neurons (arrows), indicating no nerve
degeneration in D2.Lyst
bg-J compared to B6-Lyst
bg-J age-matched
controls (n=5 for each strain). (C, D) Cross sections of sciatic
nerves stained with toluidine blue reveal a similar density of
myelinated axons with no overt degeneration in D2.Lyst
bg-J
compared to B6-Lyst
bg-J age-matched controls (n=5 for each
strain). Scale bars=10 mm. All mice=17–20 months of age.
Found at: doi:10.1371/journal.pgen.1001008.s006 (6.08 MB TIF)
Figure S7 Lyst and Tyrp1 are expressed in the mouse brain. RT-
PCR analysis shows Lyst expression in the cerebral cortex,
cerebellum, and brain stem (top panel), and Tyrp1 expression in
the cerebellum and brain stem but not the cerebral cortex (bottom
panel).
Found at: doi:10.1371/journal.pgen.1001008.s007 (0.20 MB TIF)
Video S1 D2.Lyst
bg-J mice develop a severe tremor indicative of a
neurodegenerative phenotype. Note that the D2.Lyst
bg-J mouse on
the left (lighter coat color) has a severe tremor, whereas the B6-Lyst
bg-J
mouse on the right (darker coat color) does not.
Found at: doi:10.1371/journal.pgen.1001008.s008 (1.08 MB
WMV)
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